TL;DR: The Centers for Medicare & Medicaid Services modified NCD 203 governing ultrafiltration monitor coverage, effective March 7, 2026. Here's what billing teams need to know before submitting claims.
CMS ultrafiltration monitor coverage policy under NCD 203 Medicare draws a hard line between covered and non-covered use. The covered service—ultrafiltration monitoring as a component of hemodialysis for ESRD patients with difficult fluid management problems—remains reimbursable. Standalone ultrafiltration, independent of conventional dialysis, is classified as experimental and is not covered. This distinction is the crux of every claim submission decision your team will make on this equipment.
Quick-Reference: NCD 203 CMS Ultrafiltration Monitor Policy 2026
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Ultrafiltration Monitor — NCD 203 |
| Policy Code | NCD 203 |
| Change Type | Modified |
| Effective Date | March 7, 2026 |
| Impact Level | Medium |
| Specialties Affected | Nephrology, Home Dialysis, ESRD Programs, Durable Medical Equipment suppliers |
| Key Action | Confirm that all ultrafiltration monitor claims document use as a component of hemodialysis—not as a standalone procedure—before billing Medicare |
CMS Ultrafiltration Monitor Coverage Criteria and Medical Necessity Requirements 2026
NCD 203 is the National Coverage Determination governing Medicare coverage of the ultrafiltration monitor under the Home Dialysis Supplies and Equipment benefit category. The policy is clear on when this device is a covered service and when it is not.
The ultrafiltration monitor is covered when it does two things: functions as a component of hemodialysis, and is used to calculate fluid rates for ESRD patients who present difficult fluid management problems. Both conditions must apply. One without the other does not satisfy the coverage policy.
Medical necessity under this NCD is determined on a case-by-case basis. That means your team cannot apply a blanket approval to all ultrafiltration monitor claims. Each claim needs individual documentation that the specific patient presents difficult fluid management challenges during hemodialysis.
The device itself addresses a real clinical problem: overfiltration removes too much fluid from body tissues, and underfiltration removes too little. The monitor helps calculate the right fluid removal rate. But CMS reimbursement hinges on how the device is used—not just that it was used.
Whether ultrafiltration monitoring is covered under Medicare depends entirely on its role in the dialysis session. If it's supporting conventional hemodialysis for a complex ESRD patient, you have a covered service. If it's being billed as a standalone treatment outside that context, you have an experimental designation and a likely claim denial.
Prior authorization requirements are not explicitly detailed within the NCD text itself. However, given that medical necessity is assessed case by case, your Medicare Administrative Contractor may impose local documentation requirements. Check with your MAC before the effective date of March 7, 2026 to confirm what your contractor expects.
CMS Ultrafiltration Monitor Exclusions and Non-Covered Indications
This section matters as much as the covered criteria—maybe more, because it's where the denials live.
CMS draws one categorical exclusion: ultrafiltration performed independent of conventional dialysis. If the technology is designed exclusively for standalone ultrafiltration—meaning it's not functioning as part of a hemodialysis session—it is not covered under Medicare. CMS classifies this use as experimental.
This is a structural exclusion, not a documentation gap you can fix with better notes. No amount of clinical justification changes the coverage status. If a device is used solely for standalone ultrafiltration, the coverage policy does not cover it.
The real issue here is that "difficult fluid management problems" is doing a lot of work in this policy. CMS doesn't define the term precisely within NCD 203. That ambiguity creates billing risk. Your clinical documentation needs to establish why this patient's fluid management is complex enough to require the monitor—not just note that the monitor was used.
If you're billing for cases that sit at the edge of this definition, talk to your compliance officer before the March 7, 2026 effective date. The case-by-case medical necessity standard invites scrutiny, and auditors will look at whether the documentation actually supports the complexity claim.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Ultrafiltration monitoring as a component of hemodialysis for ESRD patients with difficult fluid management problems | Covered | Not specified in NCD 203 | Medical necessity determined case by case; documentation of complex fluid management required |
| Ultrafiltration independent of conventional dialysis | Not Covered / Experimental | Not specified in NCD 203 | Technology exclusively designed for standalone ultrafiltration is excluded |
CMS Ultrafiltration Monitor Billing Guidelines and Action Items 2026
The modified coverage policy is active as of March 7, 2026. Here's what your team needs to do now.
| # | Action Item |
|---|---|
| 1 | Audit your current ultrafiltration monitor claims for the hemodialysis linkage. Every claim should show that the monitor was used as a component of hemodialysis—not as a standalone procedure. Pull a sample of recent claims and check that documentation before billing goes out under the modified policy. |
| 2 | Establish a documentation template that captures "difficult fluid management." Because medical necessity is case by case, your clinical team needs a consistent way to document why this patient qualifies. Work with your nephrologists to define what the documentation should include—fluid imbalance history, failed management attempts, or other clinical indicators that justify use of the monitor. |
| 3 | Flag any standalone ultrafiltration billing immediately. If your charge capture includes codes for ultrafiltration independent of conventional dialysis, stop those claims. They will not be covered under CMS billing guidelines. This isn't a gray area—it's a categorical exclusion. |
| 4 | Contact your MAC to confirm local documentation requirements. NCD 203 defers medical necessity to case-by-case review, which means your Medicare Administrative Contractor may have issued a local coverage determination with more specific criteria. Call or check your MAC's website before March 7, 2026. |
| 5 | Update your charge capture and coding workflows to reflect the covered-versus-excluded distinction. Your billing team should not be making real-time coverage calls on this. Build the distinction into the workflow: hemodialysis component with complex fluid management equals billable; standalone ultrafiltration equals non-billable. Make that decision upstream, not at claim submission. |
| 6 | Review your ESRD program's durable medical equipment billing for any crossover claims. If you bill for home dialysis equipment, confirm that any ultrafiltration monitor supplied for home use is documented as part of a hemodialysis regimen—not as a separate device for standalone treatment. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Ultrafiltration Monitor Under NCD 203
Covered Codes
NCD 203 does not list specific CPT or HCPCS codes in the policy data. CMS has not published code-level billing guidelines within this NCD document.
This is a meaningful gap for your billing team. Without specified codes, you're relying on your MAC's guidance and your internal coding team to assign the correct HCPCS level II codes for the equipment and the associated hemodialysis services. Contact your MAC or consult with your billing consultant to confirm the right codes for your claims.
Not Covered / Experimental Codes
| Indication | Status | Notes |
|---|---|---|
| Standalone ultrafiltration (independent of conventional dialysis) | Not Covered — Experimental | No codes specified in NCD 203; any technology billed exclusively for this purpose is excluded |
Key ICD-10-CM Diagnosis Codes
NCD 203 does not specify ICD-10-CM codes. ESRD diagnosis codes are the relevant diagnosis category, but the NCD does not enumerate them. Work with your coding team to confirm appropriate ICD-10 codes that support the hemodialysis and difficult fluid management documentation in each claim.
A Note on the Missing Codes
The absence of specific codes in NCD 203 is worth flagging directly. Most coverage policies at this stage include at least HCPCS level II codes for durable medical equipment. The fact that NCD 203 references "Claims Processing Instructions" as a cross-reference suggests the coding detail may live in a separate instruction document.
Request the associated Claims Processing Instructions from your MAC or check the CMS Transmittals database. That document likely contains the billing codes your team needs for ultrafiltration monitor billing. Don't submit claims without confirming the correct codes through that source first.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.